test44
https://www.cytel.com/blog/how-to-use-a-living-hta-approach-to-demonstrate-value-in-real-time
May 27, 2022
When submitting systematic literature reviews to a Health Technology Assessment authority, high volumes of research..
Read article
test44
https://www.cytel.com/blog/estimands-estimators-estimates-aligning-target-of-estimation-method-of-estimation-and-sensitivity-analysis-with-application-to-the-covid-19-pandemic
May 26, 2022
When constructing estimands a key question that arises is how to handle intercurrent events and missing data. In a..
Read article
test44
https://www.cytel.com/blog/leveraging-advanced-statistical-software-to-optimize-clinical-development
May 24, 2022
Traditionally, clinical trials are expensive, long in duration, and have low success rate. But with the advent of rich..
Read article
test44
https://www.cytel.com/blog/together-trial-wins-society-of-clinical-trials-david-sackett-trial-of-the-year-award
May 17, 2022
Early in the pandemic, it became clear that many of the COVID-19 therapies being tested in wealthier nations, were not..
Read article
test44
https://www.cytel.com/blog/cytel-australian-research-council-collaborate-to-strengthen-early-phase-capabilities
May 16, 2022
A combination of industry and policy forces have recently changed the shape of Australia’s R&D sector, making it a..
Read article
test44
https://www.cytel.com/blog/estimator-choice-in-synthetic-control-arm-analyses-an-ispor-podium-presentation-by-cytel
May 12, 2022
Synthetic control arm (SCA) methods are statistical methods that are seeing rapidly increasing use in comparative..
Read article
test44
https://www.cytel.com/blog/an-interview-with-grammati-sarri-on-moderating-an-issue-panel-at-ispor-us-2022-0
May 5, 2022
While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..
Read article
test44
https://www.cytel.com/blog/optimizing-human-machine-partnership-for-up-to-date-evidence
May 4, 2022
If you are a pharmaceutical or biotech company seeking to enter the market with a new drug, you need to submit a..
Read article
test44
https://www.cytel.com/blog/adaptive-designs-for-early-phase-development-are-we-asking-the-right-questions
May 3, 2022
In 2005, Pfizer launched a Phase 1 trial for the kinase inhibitor crizotinib. Six years later, it was approved, thanks..
Read article
